文献速递脊柱脊髓外科

退行性脊髓型颈椎病患者晚期糖基化终末产物无创皮肤自发荧光研究

Noninvasive Skin Autofluorescence of Advanced Glycation End Products in Patients with Degenerative Cervical Myelopathy.
PubMed 文献 · World Neurosurg · 2024-12-28

该前瞻性研究纳入93例退行性脊髓型颈椎病患者,按AGE评分0.54分为低分组41例和高分组52例。两组人口学、实验室、最大脊髓压迫和临床结局可比,但高分组腿部和足部疼痛NRS评分显著更高;多因素线性回归显示较高AGE评分与更严重下肢疼痛显著相关。作者认为AGE皮肤自发荧光可能是有用的下肢疼痛生物标志物。

要点

  • 以AGE评分0.54为界,退行性脊髓型颈椎病患者分为低分组41例和高分组52例。
  • 高分组腿部和足部疼痛NRS评分显著高于低分组。
  • 较高AGE评分与更严重下肢疼痛显著相关。

核心结论

  • 晚期糖基化终末产物无创皮肤自发荧光可能作为退行性脊髓型颈椎病患者下肢疼痛症状的有用生物标志物。

研究设计与样本

  • 前瞻性纳入连续退行性脊髓型颈椎病患者,于中指指尖检测皮肤自发荧光AGE评分,以0.54为界分为低分组和高分组。
  • 共263例患者中93例纳入分析,低分组41例,高分组52例。

主要发现

  • 两组人口学数据、实验室数据、最大脊髓压迫和临床结局(欧洲五维健康量表、颈部功能障碍指数、日本骨科协会评分)可比。
  • 高分组腿部和足部疼痛NRS评分显著高于低分组。
  • 多因素线性回归分析显示,较高AGE评分与退行性脊髓型颈椎病患者更严重下肢疼痛显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify the association between skin autofluorescence of advanced glycation end products (AGEs) and clinical outcomes and pain in patients with degenerative cervical myelopathy (DCM). METHODS: Consecutive patients with DCM were prospectively enrolled. AGEs assessed by skin autofluorescence (the AGE score) were examined at the middle fingertip in eligible patients. Patients were divided into lower AGE score (AGE-L) and higher AGE score (AGE-H) groups based on a cutoff AGE score of 0.54. Demographic data, laboratory data, maximum spinal cord compression, clinical outcomes, such as European Quality of Life-5 Dimensions, Neck Disability Index, and Japanese Orthopaedic Association score, and Numerical Rating Scale (NRS) score for neck, arm, hand, leg, and foot pain were compared between the two groups. Multiple linear regression analysis was performed to assess the association between the AGE score and the NRS score for pain in the lower limbs. RESULTS: Of the 263 patients, 93 were included in this study (41 with the AGE-L group and 52 with the AGE-H group). Demographic data, laboratory data, maximum spinal cord compression, and clinical outcomes were comparable between the two groups. The AGE-H group had significantly higher NRS scores for leg and foot pain than the AGE-L group. Multiple linear regression analysis revealed that higher AGE scores were significantly associated with more severe pain in the lower limbs in patients with DCM. CONCLUSIONS: Noninvasive skin autofluorescence of AGEs may be a useful biomarker for pain symptoms in the lower limbs in patients with DCM.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Doi T, Inoue T, Sugaya J, et al. Noninvasive Skin Autofluorescence of Advanced Glycation End Products in Patients with Degenerative Cervical Myelopathy. World Neurosurg. 2024. PMID: 39653077. doi:10.1016/j.wneu.2024.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。